{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T06:06:57Z","timestamp":1775110017902,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071431"],"award-info":[{"award-number":["82071431"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s12035-023-03345-4","type":"journal-article","created":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T14:01:21Z","timestamp":1683381681000},"page":"4738-4752","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Involvement of Abnormal p-\u03b1-syn Accumulation and TLR2-Mediated Inflammation of Schwann Cells in Enteric Autonomic Nerve Dysfunction of Parkinson\u2019s Disease: an Animal Model Study"],"prefix":"10.1007","volume":"60","author":[{"given":"Wenwen","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4437-1095","authenticated-orcid":false,"given":"Kezhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,6]]},"reference":[{"key":"3345_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/s0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386:896\u2013912. https:\/\/doi.org\/10.1016\/s0140-6736(14)61393-3","journal-title":"Lancet"},{"key":"3345_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","volume":"396","author":"H Braak","year":"2006","unstructured":"Braak H, Vos RAID, Bohl J, Tredici KD (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology. Neurosci Lett 396:67\u201372. https:\/\/doi.org\/10.1016\/j.neulet.2005.11.012","journal-title":"Neurosci Lett"},{"key":"3345_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","volume":"14","author":"A Fasano","year":"2015","unstructured":"Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF (2015) Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol 14:625\u2013639. https:\/\/doi.org\/10.1016\/S1474-4422(15)00007-1","journal-title":"Lancet Neurol"},{"key":"3345_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Tredici KD, R\u00fcb U, Vos RAID, Steur ENHJ, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"3345_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrn3617","volume":"15","author":"DN Xanthos","year":"2014","unstructured":"Xanthos DN, Sandkuhler J (2014) Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity. Nat Rev Neurosci 15:43\u201353. https:\/\/doi.org\/10.1038\/nrn3617","journal-title":"Nat Rev Neurosci"},{"key":"3345_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener 4:19. https:\/\/doi.org\/10.1186\/s40035-015-0042-0","journal-title":"Transl Neurodegener"},{"key":"3345_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","volume":"34","author":"T Kawai","year":"2011","unstructured":"Kawai T, Akira S (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637\u2013650. https:\/\/doi.org\/10.1016\/j.immuni.2011.05.006","journal-title":"Immunity"},{"key":"3345_CR8","doi-asserted-by":"publisher","first-page":"672395","DOI":"10.1155\/2010\/672395","volume":"2010","author":"AM Piccinini","year":"2010","unstructured":"Piccinini AM, Midwood KS (2010) DAMPening inflammation by modulating TLR signalling. Mediators Inflamm 2010:672395. https:\/\/doi.org\/10.1155\/2010\/672395","journal-title":"Mediators Inflamm"},{"key":"3345_CR9","doi-asserted-by":"publisher","first-page":"ra45","DOI":"10.1126\/scisignal.2005965","volume":"8","author":"SG Daniele","year":"2015","unstructured":"Daniele SG, Beraud D, Davenport C, Cheng K, Yin H, Maguire-Zeiss KA (2015) Activation of MyD88-dependent TLR1\/2 signaling by misfolded alpha-synuclein, a protein linked to neurodegenerative disorders. Sci Signal 8:ra45. https:\/\/doi.org\/10.1126\/scisignal.2005965","journal-title":"Sci Signal"},{"key":"3345_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","volume":"109","author":"EM Rocha","year":"2018","unstructured":"Rocha EM, De Miranda B, Sanders LH (2018) Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Neurobiol Dis 109:249\u2013257. https:\/\/doi.org\/10.1016\/j.nbd.2017.04.004","journal-title":"Neurobiol Dis"},{"key":"3345_CR11","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/cns.13282","volume":"26","author":"H Zhang","year":"2020","unstructured":"Zhang H, Wu J, Shen F-F, Yuan YS, Li X, Ji P et al (2020) Activated Schwann cells and increased inflammatory cytokines IL-1beta, IL-6, and TNF-alpha in patients\u2019 sural nerve are lack of tight relationship with specific sensory disturbances in Parkinson\u2019s disease. CNS Neurosci Ther 26:518\u2013526. https:\/\/doi.org\/10.1111\/cns.13282","journal-title":"CNS Neurosci Ther"},{"key":"3345_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.parkreldis.2018.10.003","volume":"60","author":"H Zhang","year":"2019","unstructured":"Zhang H, Zhu L, Sun L, Zhi Y, Ding J, Yuan YS et al (2019) Phosphorylated alpha-synuclein deposits in sural nerve deriving from Schwann cells: a biomarker for Parkinson\u2019s disease. Parkinsonism Relat Disord 60:57\u201363. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.10.003","journal-title":"Parkinsonism Relat Disord"},{"key":"3345_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41420-021-00676-w","volume":"7","author":"L Sun","year":"2021","unstructured":"Sun L, Jiang WW, Wang Y, Yuan YS, Rong Z, Wu J et al (2021) Phosphorylated \u03b1-synuclein aggregated in Schwann cells exacerbates peripheral neuroinflammation and nerve dysfunction in Parkinson\u2019s disease through TLR2\/NF-\u03baB pathway. Cell Death Discov 7:289. https:\/\/doi.org\/10.1038\/s41420-021-00676-w","journal-title":"Cell Death Discov"},{"key":"3345_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.nbd.2013.03.005","volume":"55","author":"E Ydens","year":"2013","unstructured":"Ydens E, Lornet G, Smits V, Goethals S, Timmerman V, Janssens S (2013) The neuroinflammatory role of Schwann cells in disease. Neurobiol Dis 55:95\u2013103. https:\/\/doi.org\/10.1016\/j.nbd.2013.03.005","journal-title":"Neurobiol Dis"},{"key":"3345_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3233\/JPD-2011-11033","volume":"1","author":"JG Greene","year":"2011","unstructured":"Greene JG (2011) Animal models of gastrointestinal problems in Parkinson\u2019s disease. J Parkinson\u2019s Dis 1:137\u2013149. https:\/\/doi.org\/10.3233\/JPD-2011-11033","journal-title":"J Parkinson\u2019s Dis"},{"key":"3345_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.bbi.2019.07.009","volume":"81","author":"ZL Hu","year":"2019","unstructured":"Hu ZL, Sun T, Lu M, Ding JH, Du RH, Hu G (2019) Kir6.1\/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson\u2019s disease via promoting mitophagy. Brain Behav Immun 81:509\u2013522. https:\/\/doi.org\/10.1016\/j.bbi.2019.07.009","journal-title":"Brain Behav Immun"},{"key":"3345_CR17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/jnc.15368","volume":"158","author":"F Lin","year":"2021","unstructured":"Lin F, Shan W, Zheng Y, Pan L, Zuo Z (2021) Toll-like receptor 2 activation and up-regulation by high mobility group box-1 contribute to post-operative neuroinflammation and cognitive dysfunction in mice. J Neurochem 158:328\u2013341. https:\/\/doi.org\/10.1111\/jnc.15368","journal-title":"J Neurochem"},{"key":"3345_CR18","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/jam.14338","volume":"127","author":"JF Fonseca","year":"2019","unstructured":"Fonseca JF, Alvim LB, Nunes \u00c1C, Oliveira FMS, Amaral RS, Caliari MV et al (2019) Probiotic effect of Bifidobacterium longum 5(1A) and Weissella paramesenteroides WpK4 on gerbils infected with Giardia lamblia. J Appl Microbiol 127:1184\u20131191. https:\/\/doi.org\/10.1111\/jam.14338","journal-title":"J Appl Microbiol"},{"key":"3345_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbi.2019.06.042","volume":"81","author":"A Kouli","year":"2019","unstructured":"Kouli A, Horne CB, Williams-Gray CH (2019) Toll-like receptors and their therapeutic potential in Parkinson\u2019s disease and alpha-synucleinopathies. Brain Behav Immun 81:41\u201351. https:\/\/doi.org\/10.1016\/j.bbi.2019.06.042","journal-title":"Brain Behav Immun"},{"key":"3345_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fncel.2018.00329","volume":"12","author":"BL Fiebich","year":"2018","unstructured":"Fiebich BL, Batista CRA, Saliba SW, Yousif NM, de Oliveira ACP (2018) Role of microglia TLRs in neurodegeneration. Front Cell Neurosci 12:329. https:\/\/doi.org\/10.3389\/fncel.2018.00329","journal-title":"Front Cell Neurosci"},{"key":"3345_CR21","doi-asserted-by":"publisher","first-page":"754475","DOI":"10.3389\/fimmu.2021.754475","volume":"12","author":"O Martin-Rodriguez","year":"2021","unstructured":"Martin-Rodriguez O, Gauthier T, Bonnefoy F, Couturier M, Daoui A, Chague C et al (2021) Pro-resolving factors released by macrophages after efferocytosis promote mucosal wound healing in inflammatory bowel disease. Front Immunol 12:754475. https:\/\/doi.org\/10.3389\/fimmu.2021.754475","journal-title":"Front Immunol"},{"key":"3345_CR22","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1053\/j.gastro.2018.11.029","volume":"156","author":"K Scheibe","year":"2019","unstructured":"Scheibe K, Kersten C, Schmied A, Vieth M, Primbs T, Carle B et al (2019) Inhibiting interleukin 36 receptor signaling reduces fibrosis in mice with chronic intestinal inflammation. Gastroenterology 156:1082-1097.e1011. https:\/\/doi.org\/10.1053\/j.gastro.2018.11.029","journal-title":"Gastroenterology"},{"key":"3345_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/apt.13746","volume":"44","author":"MR Blake","year":"2016","unstructured":"Blake MR, Raker JM, Whelan K (2016) Validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 44:693\u2013703. https:\/\/doi.org\/10.1111\/apt.13746","journal-title":"Aliment Pharmacol Ther"},{"key":"3345_CR24","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/mds.27794","volume":"34","author":"K Tsukita","year":"2019","unstructured":"Tsukita K, Sakamaki-Tsukita H, Tanaka K, Suenaga T, Takahashi R (2019) Value of in vivo alpha-synuclein deposits in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 34:1452\u20131463. https:\/\/doi.org\/10.1002\/mds.27794","journal-title":"Mov Disord"},{"key":"3345_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11894-018-0609-x","volume":"20","author":"A Sharma","year":"2018","unstructured":"Sharma A, Kurek J, Morgan JC, Wakade C, Rao SSC (2018) Constipation in Parkinson\u2019s disease: a nuisance or nuanced answer to the pathophysiological puzzle? Curr Gastroenterol Rep 20:1\u20139. https:\/\/doi.org\/10.1007\/s11894-018-0609-x","journal-title":"Curr Gastroenterol Rep"},{"key":"3345_CR26","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1007\/s12035-016-9803-8","volume":"54","author":"AM Delattre","year":"2017","unstructured":"Delattre AM, Carabelli B, Mori MA, Kempe PG, Rizzo de Souza LE, Zanata SM et al (2017) Maternal omega-3 supplement improves dopaminergic system in pre- and postnatal inflammation-induced neurotoxicity in Parkinson\u2019s disease model. Mol Neurobiol 54:2090\u20132106. https:\/\/doi.org\/10.1007\/s12035-016-9803-8","journal-title":"Mol Neurobiol"},{"key":"3345_CR27","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/WNR.0000000000000548","volume":"27","author":"L Cao","year":"2016","unstructured":"Cao L, Li D, Feng P, Li L, Xue GF, Li G et al (2016) A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson\u2019s disease by reducing chronic inflammation in the brain. NeuroReport 27:384\u2013391. https:\/\/doi.org\/10.1097\/WNR.0000000000000548","journal-title":"NeuroReport"},{"key":"3345_CR28","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM (2016) How neuroinflammation contributes to neurodegeneration. Science 353:777\u2013783. https:\/\/doi.org\/10.1126\/science.aag2590","journal-title":"Science"},{"key":"3345_CR29","doi-asserted-by":"publisher","unstructured":"Mendes-Pinheiro B, Soares-Cunha C, Marote A, Loureiro-Campos E, Campos J, Barata-Antunes S et al (2021) Unilateral intrastriatal 6-hydroxydopamine lesion in mice: a closer look into non-motor phenotype and glial response. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms222111530","DOI":"10.3390\/ijms222111530"},{"key":"3345_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.expneurol.2007.05.010","volume":"207","author":"G Anderson","year":"2007","unstructured":"Anderson G, Noorian AR, Taylor G, Anitha M, Bernhard D, Srinivasan S et al (2007) Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson\u2019s disease. Exp Neurol 207:4\u201312. https:\/\/doi.org\/10.1016\/j.expneurol.2007.05.010","journal-title":"Exp Neurol"},{"key":"3345_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12031-011-9560-0","volume":"47","author":"HC Zhu","year":"2012","unstructured":"Zhu HC, Zhao J, Luo CY, Li QQ (2012) Gastrointestinal dysfunction in a Parkinson\u2019s disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus. J Mol Neurosci 47:15\u201325. https:\/\/doi.org\/10.1007\/s12031-011-9560-0","journal-title":"J Mol Neurosci"},{"key":"3345_CR32","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/s0140-6736(95)92707-7","volume":"346","author":"C Singaram","year":"1995","unstructured":"Singaram C, Ashraf W, Gaumnitz EA, Torbey C, Sengupta A, Pfeiffer R et al (1995) Dopaminergic defect of enteric nervous system in Parkinson\u2019s disease patients with chronic constipation. Lancet 346:861\u2013864. https:\/\/doi.org\/10.1016\/s0140-6736(95)92707-7","journal-title":"Lancet"},{"key":"3345_CR33","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1007\/s11064-018-2620-x","volume":"43","author":"F Lai","year":"2018","unstructured":"Lai F, Jiang R, Xie W, Liu X, Tang Y, Xiao H et al (2018) Intestinal pathology and gut microbiota alterations in a methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson\u2019s disease. Neurochem Res 43:1986\u20131999. https:\/\/doi.org\/10.1007\/s11064-018-2620-x","journal-title":"Neurochem Res"},{"key":"3345_CR34","doi-asserted-by":"publisher","first-page":"599045","DOI":"10.3389\/fnagi.2020.599045","volume":"12","author":"NR Han","year":"2020","unstructured":"Han NR, Kim YK, Ahn S, Hwang TY, Lee H, Park HJ (2020) A comprehensive phenotype of non-motor impairments and distribution of alpha-synuclein deposition in parkinsonism-induced mice by a combination injection of MPTP and probenecid. Front Aging Neurosci 12:599045. https:\/\/doi.org\/10.3389\/fnagi.2020.599045","journal-title":"Front Aging Neurosci"},{"key":"3345_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.brainres.2010.07.076","volume":"1355","author":"G Natale","year":"2010","unstructured":"Natale G, Kastsiushenka O, Fulceri F, Ruggieri S, Paparelli A, Fornai F (2010) MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut. Brain Res 1355:195\u2013206. https:\/\/doi.org\/10.1016\/j.brainres.2010.07.076","journal-title":"Brain Res"},{"key":"3345_CR36","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1002\/mds.26702","volume":"31","author":"L Antunes","year":"2016","unstructured":"Antunes L, Frasquilho S, Ostaszewski M, Weber J, Longhino L, Antony P et al (2016) Similar alpha-Synuclein staining in the colon mucosa in patients with Parkinson\u2019s disease and controls. Mov Disord 31:1567\u20131570. https:\/\/doi.org\/10.1002\/mds.26702","journal-title":"Mov Disord"},{"key":"3345_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/nan.12531","volume":"45","author":"NN Vaikath","year":"2019","unstructured":"Vaikath NN, Erskine D, Morris CM, Majbour NK, Vekrellis K, Li JY et al (2019) Heterogeneity in alpha-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 45:597\u2013608. https:\/\/doi.org\/10.1111\/nan.12531","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3345_CR38","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/mds.25979","volume":"30","author":"T Clairembault","year":"2015","unstructured":"Clairembault T, Leclair-Visonneau L, Neunlist M, Derkinderen P (2015) Enteric glial cells: new players in Parkinson\u2019s disease? Mov Disord 30:494\u2013498. https:\/\/doi.org\/10.1002\/mds.25979","journal-title":"Mov Disord"},{"key":"3345_CR39","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1111\/j.1582-4934.2010.01127.x","volume":"14","author":"Y Li","year":"2010","unstructured":"Li Y, Wang L, Chen S (2010) Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med 14:2592\u20132603. https:\/\/doi.org\/10.1111\/j.1582-4934.2010.01127.x","journal-title":"J Cell Mol Med"},{"key":"3345_CR40","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/glia.21041","volume":"58","author":"S Goethals","year":"2010","unstructured":"Goethals S, Ydens E, Timmerman V, Janssens S (2010) Toll-like receptor expression in the peripheral nerve. Glia 58:1701\u20131709. https:\/\/doi.org\/10.1002\/glia.21041","journal-title":"Glia"},{"key":"3345_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-018-0276-2","volume":"13","author":"C Kim","year":"2018","unstructured":"Kim C, Spencer B, Rockenstein E, Yamakado H, Mante M, Adame A et al (2018) Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating alpha-synuclein transmission and neuroinflammation. Mol Neurodegener 13:43. https:\/\/doi.org\/10.1186\/s13024-018-0276-2","journal-title":"Mol Neurodegener"},{"key":"3345_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fnagi.2020.00068","volume":"12","author":"A Bellucci","year":"2020","unstructured":"Bellucci A, Bubacco L, Longhena F, Parrella E, Faustini G, Porrini V et al (2020) Nuclear factor-kappaB dysregulation and alpha-synuclein pathology: critical interplay in the pathogenesis of Parkinson\u2019s disease. Front Aging Neurosci 12:68. https:\/\/doi.org\/10.3389\/fnagi.2020.00068","journal-title":"Front Aging Neurosci"},{"key":"3345_CR43","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1084\/jem.20140654","volume":"212","author":"MS Baig","year":"2015","unstructured":"Baig MS, Zaichick SV, Mao M, de Abreu AL, Bakhshi FR, Hart PC et al (2015) NOS1-derived nitric oxide promotes NF-kappaB transcriptional activity through inhibition of suppressor of cytokine signaling-1. J Exp Med 212:1725\u20131738. https:\/\/doi.org\/10.1084\/jem.20140654","journal-title":"J Exp Med"},{"key":"3345_CR44","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3389\/fimmu.2019.01043","volume":"10","author":"EC Dresselhaus","year":"2019","unstructured":"Dresselhaus EC, Meffert MK (2019) Cellular specificity of NF-kappaB function in the nervous system. Front Immunol 10:1043. https:\/\/doi.org\/10.3389\/fimmu.2019.01043","journal-title":"Front Immunol"},{"key":"3345_CR45","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.3390\/ijms18122633","volume":"18","author":"AA Boyko","year":"2017","unstructured":"Boyko AA, Troyanova NI, Kovalenko EI, Sapozhnikov AM (2017) Similarity and differences in inflammation-related characteristics of the peripheral immune system of patients with Parkinson\u2019s and Alzheimer\u2019s diseases. Int J Mol Sci 18:2633. https:\/\/doi.org\/10.3390\/ijms18122633","journal-title":"Int J Mol Sci"},{"key":"3345_CR46","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/ni.2231","volume":"13","author":"L Franchi","year":"2012","unstructured":"Franchi L, Munoz-Planillo R, N\u00fa\u00f1ez G (2012) Sensing and reacting to microbes through the inflammasomes. Nat Immunol 13:325\u2013332. https:\/\/doi.org\/10.1038\/ni.2231","journal-title":"Nat Immunol"},{"key":"3345_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2018.02.003","volume":"288","author":"L Wen","year":"2018","unstructured":"Wen L, Zhang QS, Heng Y, Chen Y, Wang S, Yuan YH et al (2018) NLRP3 inflammasome activation in the thymus of MPTP-induced Parkinsonian mouse model. Toxicol Lett 288:1\u20138. https:\/\/doi.org\/10.1016\/j.toxlet.2018.02.003","journal-title":"Toxicol Lett"},{"key":"3345_CR48","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1124\/jpet.117.244020","volume":"363","author":"QS Zhang","year":"2017","unstructured":"Zhang QS, Heng Y, Chen Y, Luo P, Wen L, Zhang Z et al (2017) A novel bibenzyl compound (20C) protects mice from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\/probenecid toxicity by regulating the alpha-synuclein-related inflammatory response. J Pharmacol Exp Ther 363:284\u2013292. https:\/\/doi.org\/10.1124\/jpet.117.244020","journal-title":"J Pharmacol Exp Ther"},{"key":"3345_CR49","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/s1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417\u2013426. https:\/\/doi.org\/10.1016\/s1097-2765(02)00599-3","journal-title":"Mol Cell"},{"key":"3345_CR50","doi-asserted-by":"publisher","first-page":"104821","DOI":"10.1016\/j.nbd.2020.104821","volume":"139","author":"C Pellegrini","year":"2020","unstructured":"Pellegrini C, Ippolito C, Segnani C, Dolfi A, Errede M, Virgintino D et al (2020) Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration. Neurobiol Dis 139:104821. https:\/\/doi.org\/10.1016\/j.nbd.2020.104821","journal-title":"Neurobiol Dis"},{"key":"3345_CR51","doi-asserted-by":"publisher","first-page":"135964","DOI":"10.1016\/j.neulet.2021.135964","volume":"756","author":"Z Rong","year":"2021","unstructured":"Rong Z, Shen F, Wang Y, Sun L, Wu J, Zhang H et al (2021) Phosphorylated alpha-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson\u2019s disease from multiple system atrophy and progressive supranuclear paralysis. Neurosci Lett 756:135964. https:\/\/doi.org\/10.1016\/j.neulet.2021.135964","journal-title":"Neurosci Lett"},{"key":"3345_CR52","doi-asserted-by":"publisher","first-page":"a020487","DOI":"10.1101\/cshperspect.a020487","volume":"7","author":"KR Jessen","year":"2015","unstructured":"Jessen KR, Mirsky R, Lloyd AC (2015) Schwann cells: development and role in nerve repair. Cold Spring Harb Perspect Biol 7:a020487. https:\/\/doi.org\/10.1101\/cshperspect.a020487","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3345_CR53","doi-asserted-by":"publisher","first-page":"323","DOI":"10.26355\/eurrev_202001_19929","volume":"24","author":"R Di Liddo","year":"2020","unstructured":"Di Liddo R, Piccione M, Schrenk S, Dal Magro C, Cosma C, Padoan A et al (2020) S100B as a new fecal biomarker of inflammatory bowel diseases. Eur Rev Med Pharmacol Sci 24:323\u2013332. https:\/\/doi.org\/10.26355\/eurrev_202001_19929","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3345_CR54","doi-asserted-by":"publisher","first-page":"739874","DOI":"10.3389\/fcimb.2021.739874","volume":"11","author":"DVS Costa","year":"2021","unstructured":"Costa DVS, Moura-Neto V, Bolick DT, Guerrant RL, Fawad JA, Shin JH et al (2021) S100B inhibition attenuates intestinal damage and diarrhea severity during clostridioides difficile infection by modulating inflammatory response. Front Cell Infect Microbiol 11:739874. https:\/\/doi.org\/10.3389\/fcimb.2021.739874","journal-title":"Front Cell Infect Microbiol"},{"key":"3345_CR55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40478-014-0090-1","volume":"2","author":"KJ Doorn","year":"2014","unstructured":"Doorn KJ, Moors T, Drukarch B, van de Berg W, Lucassen PJ, van Dam AM (2014) Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson\u2019s disease patients. Acta Neuropathol Commun 2:90. https:\/\/doi.org\/10.1186\/s40478-014-0090-1","journal-title":"Acta Neuropathol Commun"},{"key":"3345_CR56","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00401-016-1648-8","volume":"133","author":"N Dzamko","year":"2017","unstructured":"Dzamko N, Gysbers A, Perera G, Bahar A, Shankar A, Gao J et al (2017) Toll-like receptor 2 is increased in neurons in Parkinson\u2019s disease brain and may contribute to alpha-synuclein pathology. Acta Neuropathol 133:303\u2013319. https:\/\/doi.org\/10.1007\/s00401-016-1648-8","journal-title":"Acta Neuropathol"},{"key":"3345_CR57","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/ncomms2534","volume":"4","author":"C Kim","year":"2013","unstructured":"Kim C, Ho DH, Suk JE, You S, Michael S, Kang J et al (2013) Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun 4:1562. https:\/\/doi.org\/10.1038\/ncomms2534","journal-title":"Nat Commun"},{"key":"3345_CR58","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1042\/BJ20150617","volume":"471","author":"A Gustot","year":"2015","unstructured":"Gustot A, Gallea JI, Sarroukh R, Celej MS, Ruysschaert JM, Raussens V (2015) Amyloid fibrils are the molecular trigger of inflammation in Parkinson\u2019s disease. Biochem J 471:323\u2013333. https:\/\/doi.org\/10.1042\/BJ20150617","journal-title":"Biochem J"},{"key":"3345_CR59","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.4049\/jimmunol.178.10.6476","volume":"178","author":"O Hoffmann","year":"2007","unstructured":"Hoffmann O, Braun JS, Becker D, Halle A, Freyer D, Dagand E et al (2007) TLR2 mediates neuroinflammation and neuronal damage. J Immunol 178:6476\u20136481. https:\/\/doi.org\/10.4049\/jimmunol.178.10.6476","journal-title":"J Immunol"},{"key":"3345_CR60","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00109-018-1631-z","volume":"96","author":"W Xing","year":"2018","unstructured":"Xing W, Huang P, Lu Y, Zeng W, Zuo Z (2018) Amantadine attenuates sepsis-induced cognitive dysfunction possibly not through inhibiting toll-like receptor 2. J Mol Med (Berl) 96:391\u2013402. https:\/\/doi.org\/10.1007\/s00109-018-1631-z","journal-title":"J Mol Med (Berl)"},{"key":"3345_CR61","doi-asserted-by":"publisher","first-page":"4807179","DOI":"10.1155\/2020\/4807179","volume":"2020","author":"P Ugalde-Muniz","year":"2020","unstructured":"Ugalde-Muniz P, Fetter-Pruneda I, Navarro L, Garcia E, Chavarria A (2020) Chronic systemic inflammation exacerbates neurotoxicity in a Parkinson\u2019s disease model. Oxid Med Cell Longev 2020:4807179. https:\/\/doi.org\/10.1155\/2020\/4807179","journal-title":"Oxid Med Cell Longev"},{"key":"3345_CR62","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1164\/rccm.201710-2112OC","volume":"198","author":"F Lan","year":"2018","unstructured":"Lan F, Zhang N, Holtappels G, De Ruyck N, Krysko O, Van Crombruggen K et al (2018) Staphylococcus aureus induces a mucosal type 2 immune response via epithelial cell-derived cytokines. Am J Respir Crit Care Med 198:452\u2013463. https:\/\/doi.org\/10.1164\/rccm.201710-2112OC","journal-title":"Am J Respir Crit Care Med"},{"key":"3345_CR63","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1007\/s11064-021-03365-3","volume":"46","author":"J Tian","year":"2021","unstructured":"Tian J, Song T, Wang H, Wang W, Ma X, Hu Y (2021) Toll-like receptor 2 antagonist ameliorates type 2 diabetes mellitus associated neuropathic pain by repolarizing pro-inflammatory macrophages. Neurochem Res 46:2276\u20132284. https:\/\/doi.org\/10.1007\/s11064-021-03365-3","journal-title":"Neurochem Res"},{"key":"3345_CR64","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1053\/j.gastro.2013.08.047","volume":"145","author":"P Brun","year":"2013","unstructured":"Brun P, Giron MC, Qesari M, Porzionato A, Caputi V, Zoppellaro C et al (2013) Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system. Gastroenterology 145:1323\u20131333. https:\/\/doi.org\/10.1053\/j.gastro.2013.08.047","journal-title":"Gastroenterology"},{"key":"3345_CR65","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S et al (2019) Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 103:627-641.e627. https:\/\/doi.org\/10.1016\/j.neuron.2019.05.035","journal-title":"Neuron"},{"key":"3345_CR66","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.celrep.2015.09.044","volume":"13","author":"C Kim","year":"2015","unstructured":"Kim C, Rockenstein E, Spencer B, Kim HK, Adame A, Trejo M et al (2015) Antagonizing neuronal toll-like receptor 2 prevents synucleinopathy by activating autophagy. Cell Rep 13:771\u2013782. https:\/\/doi.org\/10.1016\/j.celrep.2015.09.044","journal-title":"Cell Rep"},{"key":"3345_CR67","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.phrs.2016.01.016","volume":"105","author":"S Bock","year":"2016","unstructured":"Bock S, Murgueitio MS, Wolber G, Weindl G (2016) Acute myeloid leukaemia-derived Langerhans-like cells enhance Th1 polarization upon TLR2 engagement. Pharmacol Res 105:44\u201353. https:\/\/doi.org\/10.1016\/j.phrs.2016.01.016","journal-title":"Pharmacol Res"},{"key":"3345_CR68","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan JF, O\u2019Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M et al (2019) The microbiota-gut-brain axis. Physiol Rev 99:1877\u20132013. https:\/\/doi.org\/10.1152\/physrev.00018.2018","journal-title":"Physiol Rev"},{"key":"3345_CR69","doi-asserted-by":"publisher","first-page":"15922","DOI":"10.1096\/fj.202001669R","volume":"34","author":"L Patterson","year":"2020","unstructured":"Patterson L, Allen J, Posey I, Shaw JJP, Costa-Pinheiro P, Walker SJ et al (2020) Glucosylceramide production maintains colon integrity in response to Bacteroides fragilis toxin-induced colon epithelial cell signaling. Faseb J 34:15922\u201315945. https:\/\/doi.org\/10.1096\/fj.202001669R","journal-title":"Faseb J"},{"key":"3345_CR70","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41422-019-0241-9","volume":"30","author":"EH Ahn","year":"2020","unstructured":"Ahn EH, Kang SS, Liu X, Chen G, Zhang Z, Chandrasekharan B et al (2020) Initiation of Parkinson\u2019s disease from gut to brain by \u03b4-secretase. Cell Res 30:70\u201387. https:\/\/doi.org\/10.1038\/s41422-019-0241-9","journal-title":"Cell Res"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03345-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03345-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03345-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T12:09:01Z","timestamp":1687781341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03345-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,6]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["3345"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03345-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,6]]},"assertion":[{"value":"6 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Committee of Nanjing Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}